We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The breakthrough designation was supported by a clinical trial that found the Wysa product to be more effective than standard orthopedic care and comparable to in-person psychological counseling. Read More
In a recent survey of U.S. clinicians, 95 percent agreed that IV dislodgements pose significant safety risks for patients and hospitals, the company said. Read More
Pharmaceutical manufacturers are playing something of a shell game with inhalers, maintaining their patents and market exclusivity with new products that aren’t really new, according to research reported in the journal Health Affairs. Read More
The biomarker software can help physicians direct patients into certain treatment courses or target enrollment for clinical trials, the company said. Read More
Early results from a clinical study showed a significant improvement in patients’ quality of life and an improvement in their sleep quality, the company said. Read More
A proposed in vitro diagnostics reform bill that may end up in legislation reauthorizing device user fees could have a chilling effect on the development of infectious disease-specific tests, warns the American Society for Microbiology (ASM). Read More
Parsippany, N.J.-based Extremity Medical has filed a federal patent lawsuit against competitor Fusion Orthopedics, claiming that the company, which was cofounded by a former Extremity sales representative, is infringing on two of its patents. Read More
The FDA has given Class I designation, the highest level of risk, to Avanos Medical’s March 21 recall of its Cortrak*2 enteral access system because of the potential for serious patient injury or death if the device is misused. Read More